Assistant Professor of BCMP, Dana Farber Cancer Institute
Attracting leading industry and academic experts in Medicinal Chemistry, this two-day event will bring together over 35 speakers to explore innovative new research in Protein Degradation and consider novel approaches to DNA Encoded Libraries, Phenotypic Screening and implementing Artificial Intelligence in the drug discovery process.
In addition, a special one-day symposium on Cannabinoid Drug Discovery will explore in detail the latest drug discovery developments from leading biotech and pharmaceutical companies targeting the endocannabinoid system (ECS), and creating a new class of regulated therapeutics.
“Good talks from major pharma companies about the different challenges they face and the solutions that they are applying”
“Great mix between solution provider, industrial delegates and academics”
“Networking opportunities and the excellent scientific level of the presentations”
“Very exciting program with prominent speakers”
Once again this hugely successful senior-level R&D event will be co-located with the 4th Global Pharma R&D AI, Data Science and Informatics Summit (PRADI 2020) which also explores machine learning and AI in Drug Discovery.
Watch this video from the 2019 meeting
Head of Medicinal Chemistry, Early Respiratory, Inflammation and Autoimmunity, AstraZeneca